SCHEMBL8669256

SCHEMBL8669256

CC(=O)Nc1cccc2c1CC(=O)CC2

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
ALDH1A1 P00352 5/20 0.48
MEN1 O00255 1/20 0.47
LMNA P02545 1/20 0.47
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
KMT2A Q03164 1/20 0.47
KDM4E B2RXH2 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HPGD P15428 2/20 0.42
MAOA P21397 2/20 0.42
CYP2A6 P11509 1/20 0.42
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPK1 P28482 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
SLC18A3 Q16572 1/20 0.40
TYR P14679 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326980 0.88 NPC1 (0.57) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL5129173 0.86 ALDH1A1 (0.44) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL13823608 0.84 CYP2A6 (0.46) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL5118727 0.81 ALDH1A1 (0.50) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL287047 0.80 ALDH1A1 (0.41) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL1613763 0.79 ALDH1A1 (0.68) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL1638724 0.79 ALDH1A1 (0.72) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL30567324 0.79 ALDH1A1 (0.68) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL4877265 0.78 ALDH1A1 (0.70) NPC1RAB9AALDH1A1MEN1LMNA
SCHEMBL24191934 0.77 CYP2A6 (0.47) NPC1RAB9AALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721234-A TREATING CONVULSIONS, ANXIETY, CEREBRAL HYPOXIA/ISCHEMIA, PARKINSON*S DISEASE WARNER-LAMBERT COMPANY (US) 1998-02-24 US disclosed
WO-1998005651-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYL QUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1998-02-12 WO disclosed
WO-1996017832-A1 NOVEL GLUTAMATE RECEPTOR ANTAGONISTS: FUSED CYCLOALKYLQUINOXALINEDIONES WARNER-LAMBERT COMPANY (US) 1996-06-13 WO disclosed
US-4510157-A 6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives AYERST, MCKENNA & HARRISON, INC. (CA) 1985-04-09 US disclosed